Clinical Trial Update: Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating NM8074 in patients with atypical hemolytic uremic syndrome is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Hemolytic Uremic Syndrome

Drugs mentioned

• NM8074

Snippet

Sponsor: NovelMed Therapeutics | Conditions: aHUS - Atypical Hemolytic Uremic Syndrome | Phase 2 | Status: NOT_YET_RECRUITING